120 filings
Page 2 of 6
8-K
ed0hs8cmm9qi
24 Jan 23
Regulation FD Disclosure
5:29pm
8-K
fgbp74
15 Dec 22
Verastem Oncology Appoints Rob Gagnon to Board of Directors
5:10pm
8-K
7n9nt kvq3emedh1op
9 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:03am
8-K
g3ad3kiv
7 Nov 22
Unregistered Sales of Equity Securities
7:00am
8-K
uygf1fnvn83mta
20 Oct 22
Verastem Oncology Appoints Anil Kapur to Board of Directors
8:25am
8-K
05qb0x3ko1
4 Oct 22
Corporate Presentation October 2022
4:20pm
8-K
6ojdhbon 3muu5q
30 Sep 22
Departure of Directors or Certain Officers
9:00am
8-K
50h5govxpruy4k
8 Aug 22
Verastem Oncology Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
7:41am
8-K
lv8plflkda izag
6 Jun 22
Corporate Presentation June 2022
7:58am
8-K
kpz56 cyhn
16 May 22
Submission of Matters to a Vote of Security Holders
4:25pm
8-K
r7zb69yaj8s5n5ob
30 Mar 22
Entry into a Material Definitive Agreement
8:19am
8-K
v8fh07ck t81p4e
28 Mar 22
Verastem Oncology Provides Financial Update to Support Development of VS-6766 and Defactinib in RAS Pathway-Driven Tumors
8:03am
8-K
kx85nhk1
11 Jan 22
Corporate Presentation January 2022
4:15pm
8-K
pioezxfcjr9e
26 Oct 21
Verastem Oncology Appoints Michelle Robertson to Board of Directors
8:12am
8-K
ehya3ksoyd0fx0u6 3i
24 Jun 21
Verastem Oncology Appoints Paul Bunn, M.D., and Lesley Solomon to Board of Directors
7:41am
8-K
jqa4kd f84udbpcv95z
26 May 21
Regulation FD Disclosure
8:34am
8-K
zbo1723w1k54
20 May 21
Submission of Matters to a Vote of Security Holders
11:31am
8-K
4txfivx2r cl79zk1s0
25 Feb 21
Regulation FD Disclosure
12:00am
8-K
2rsb z39kxbgw1iqgk
17 Dec 20
Regulation FD Disclosure
9:31am
8-K
euv0bviy9u 76lcx77m
30 Sep 20
Verastem Oncology Announces Closing of COPIKTRA® (duvelisib) Sale to Secura Bio
9:03am